电子预警与集束化措施用于急性肾损伤——一项澳大利亚队列研究
这项多中心研究在3家医院开展,仅H1实施包含中断式自动预警、管理指南和初级医生教育的集束化干预。6个月内639例患者发生急性肾损伤,H1的1期AKI患者住院时间更短,AKI记录率、肾内科会诊率和停用肾毒性药物率更高,但两组的住院死亡率无差异。
要点
- H1的1期AKI患者住院时间中位数为8天,对照组为10天(P=0.021)。
- H1的AKI记录率为94.8%,对照组为83.4%(P=0.001)。
- H1与对照组的住院死亡率无显著差异(11.7% vs 13.0%,P=0.71)。
核心结论
- 大多数住院患者发生1期AKI,且在社区起病并住在重症监护室之外。
- AKI电子预警集束化措施缩短了多数AKI患者的住院时间,并提高了AKI记录率、肾内科会诊率和停用肾毒性药物的比例。
研究设计与样本
- 这项多中心研究在由单一实验室服务的3家医院开展(H1为干预组,H2和H3为对照组)。
- 集束化干预仅H1实施,包括在电子病历中显示AKI分期和基线肌酐的中断式自动预警、管理指南和初级医生教育。
- 结局变量包括住院时间、全因住院死亡和管理质量。
主要发现
- 6个月内639例患者发生AKI(H1为265例,对照组为374例),其中94.7%在普通病房;537例(84%)为1期,58例(9%)为2期,43例(7%)为3期AKI。
- 住院时间中位数为9天(IQR 4-17),干预组与对照组之间无差异。
- 1期AKI患者在H1的住院时间更短(中位数8天 vs 10天,P=0.021)。
- H1的AKI记录率更高(94.8% vs 83.4%,P=0.001),肾内科会诊率更高(25% vs 19%,P=0.04),停用肾毒性药物的比例更高(25.3% vs 18.8%,P=0.045)。
- H1与对照组的住院死亡率无差异(11.7% vs 13.0%,P=0.71)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early recognition of hospital-acquired acute kidney injury (AKI) may improve patient management and outcomes. METHODS: This multicentre study was conducted at three hospitals (H1-intervention; H2 and H3-controls) served by a single laboratory. The intervention bundle [an interruptive automated alerts (aAlerts) showing AKI stage and baseline creatinine in the eMR, a management guide and junior medical staff education] was implemented only at H1. Outcome variables included length-of-stay (LOS), all-cause in-hospital mortality and management quality. RESULTS: Over 6 months, 639 patients developed AKI (265 at H1 and 374 at controls), with 94.7% in general wards; 537 (84%) patients developed Stage 1, 58 (9%) Stage 2 and 43 (7%) Stage 3 AKI. Median LOS was 9 days (IQR 4-17) and was not different between intervention and controls. However, patients with AKI stage 1 had shorter LOS at H1 [median 8 versus 10 days (P = 0.021)]. Serum creatinine had risen prior to admission in most patients. Documentation of AKI was better in H1 (94.8% versus 83.4%; P = 0.001), with higher rates of nephrology consultation (25% versus 19%; P = 0.04) and cessation of nephrotoxins (25.3 versus 18.8%; P = 0.045). There was no difference in mortality between H1 versus controls (11.7% versus 13.0%; P = 0.71). CONCLUSIONS: Most hospitalized patients developed Stage 1 AKI and developed AKI in the community and remained outside the intensive care unit (ICU). The AKI eAlert bundle reduced LOS in most patients with AKI and increased AKI documentation, nephrology consultation rate and cessation of nephrotoxic medications.
引用
- Kotwal S, Herath S, Erlich J, et al. Electronic alerts and a care bundle for acute kidney injury-an Australian cohort study. Nephrol Dial Transplant. 2023. PMID: 35438795. doi:10.1093/ndt/gfac155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。